Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision label was updated to v3.6.5, indicating a new maintenance release of the study page. No study details or content appear to have changed as part of this update.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4. This represents a minor update to the page's revision history rather than changes to the study details or user-facing content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page revision tag was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a small housekeeping update to the page's metadata rather than a change to the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a minor maintenance update to the page version without altering study details.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's Study Documents section and several blocks listing study locations, investigators, and identifiers have been removed. This reduces visibility of critical trial materials and contact information, affecting the ability to review and engage with the study record.SummaryDifference19%

- Check71 days agoChange DetectedAdded help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and header adjustments (Intervention/Treatment added; Intervention / Treatment removed) with Revision updated to v3.6.0, and the page now displays 'No longer looking for participants' to reflect closed enrollment.SummaryDifference0.4%

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.